Covea Finance’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.1M Buy
78,300
+50,300
+180% +$8.18M 0.49% 61
2026
Q2
$3.82M Hold
28,000
– – 0.12% 131
2026
Q1
$3.3M Hold
28,000
– – 0.12% 123
2025
Q4
$4.59M Buy
+28,000
New +$4.39M 0.15% 106
2023
Q4
– Sell
-8,300
Closed -$1.32M – 110
2023
Q3
$1.32M Buy
8,300
+1,300
+19% +$213K 0.07% 104
2023
Q2
$990K Hold
7,000
– – 0.05% 108
2023
Q1
$1.18M Sell
7,000
-2,000
-22% -$357K 0.07% 104
2022
Q4
$1.52M Hold
9,000
– – 0.08% 116
2022
Q3
$1.68M Buy
+9,000
New +$1.9M 0.09% 113

Other funds holding RGEN

Covea Finance's RGEN Position: Q3 2026 in Review

Covea Finance increased its Repligen (RGEN) stake by 180% in Q3 2026, buying an estimated $8.18M and bringing the position to 78,300 shares worth $15.1M. The position accounts for 0.49% of the portfolio, ranked #61.

Covea Finance first reported a position in RGEN in Q3 2022 and has held it in 9 quarters since. 524 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Covea Finance held 78,300 shares of Repligen worth $15.1M as of Q3 2026.
  • Covea Finance bought 50,300 Repligen shares in Q3 2026, an estimated $8.18M.
  • Repligen made up 0.49% of Covea Finance's portfolio in Q3 2026, its #61 holding.
  • Covea Finance first reported a position in Repligen in Q3 2022 and has held it in 9 quarters since.
  • 524 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Covea Finance's 13F filing for Q3 2026, filed 21 Oct 2026.